[Corrigendum] Lapatinib‑induced inhibition of ovarian function is counteracted by the STAT3 pathway both in vivo and in vitro

Oncol Rep. 2021 Jul;46(1):123. doi: 10.3892/or.2021.8074. Epub 2021 May 13.

Abstract

Following the publication of the above article, the authors have realized that the same image had been selected to show H&E staining of the ovarian slices in the Control and 10 μM groups in Fig. 4A. After reviewing the original pictures, the authors discovered that the image correctly showing the data for the 48 h, 10 μM group had also been used for the 48 h Control group. The corrected version of Fig. 4, showing the correct data for the 48 h Control group in Fig. 4A, is shown below. It should be noted that the inadvertent error that occurred during the compilation of this figure did not affect the results or the conclusions of this article. The authors all agree to this Corrigendum, and are grateful to the Editor of Oncology Reports for granting them the opportunity to correct this figure. The authors also apologize to the readership for any inconvenience caused. [the original article was published in Oncology Reports 44: 1127‑1135, 2020; DOI: 10.3892/or.2020.7660].

Keywords: EGF receptor; STAT3 signaling pathway; lapatinib; ovarian reserve; reproductive function.

Publication types

  • Published Erratum